Douglas Adkins - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Douglas Adkins

This paper was not found in any repository, but could be made available legally by the author.

2023 Miriam T. Jacobs

ORCID

ORCID

, Alice Y. Zhou

ORCID

, Michelle Becker-Hapak

ORCID

, Nancy D. Marin

ORCID

, Lynne Marsala

ORCID

ORCID

, Jennifer A. Foltz

ORCID

, Celia C. Cubitt

ORCID

, Jennifer Tran

ORCID

, David A. Russler-Germain

ORCID

ORCID

, Samantha Kersting-Schadek

ORCID

ORCID

, Timothy Schappe

ORCID

and 12 other authors

Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer

Upload

This paper was not found in any repository, but could be made available legally by the author.

2021 Douglas Adkins

ORCID

, Jessica Ley, Omar Atiq

ORCID

, Steven Powell

ORCID

, William C. Spanos, Mark Gitau, Caron Rigden, Kevin Palka

ORCID

ORCID

, Peter Oppelt

Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Douglas R. Adkins

ORCID

, Jin-Ching Lin, Assuntina Sacco, Jessica Ley, Peter Oppelt, Vyacheslay Vanchenko, Nataliia Komashko, Chia-J.-U.-I. Yen, Trisha Wise-Draper, Jose Lopez-Picazo Gonzalez, Sinisa Radulovic, Qi Shen, Holger Thurm, Jean-François Martini, Justin Hoffman

ORCID

and 3 other authors

Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naïve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Peter Oppelt, Jessica Ley, Mackenzie Daly, Jason Rich, Randal Paniello, Ryan S. Jackson, Patrik Pipkorn, Jingxia Liu, Hiram Gay, Kevin Palka, Prakash Neupane, Steven Powell, William C. Spanos, Mark Gitau, Jose Zevallos and 2 other authors

nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Peter Oppelt, Jessica C. Ley, Francis Worden, Kevin Palka, Ronald Maggiore

ORCID

ORCID

, Douglas Adkins

ORCID

Palbociclib and cetuximab in cetuximab-resistant human papillomavirus-related oropharynx squamous-cell carcinoma: A multicenter phase 2 trial

Upload

This paper is made freely available by the publisher.

2020 Tanguy Y. Seiwert

ORCID

, Sara Kochanny

ORCID

, Kevin Wood, Francis P. Worden, Douglas Adkins

ORCID

, James L. Wade, Bethany G. Sleckman, Daniel Anderson, Ryan J. Brisson

ORCID

, Theodore Karrison, Walter M. Stadler

ORCID

, Everett E. Vokes

ORCID

A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab‐resistant head and neck cancer: The MAESTRO study

Download from api.wiley.com

This paper was not found in any repository, but could be made available legally by the author.

2019 Thomas C. Westbrook, Ian S. Hagemann, Jessica Ley, Kevin Chen, Kevin Palka, Jingxia Liu, Ling Chen, Peter Oppelt, Douglas Adkins

ORCID

Prospective assessment of the clinical benefit of a tailored cancer gene set built on a next-generation sequencing platform in patients with recurrent or metastatic head and neck cancer

Upload

This paper was not found in any repository, but could be made available legally by the author.

Kai C. C. Johnson, Jessica Ley, Peter Oppelt, Jingxia Lu, Hiram A. Gay, Mackenzie Daly, Ryan Jackson, Jason Rich, Patrik Pipkorn, Randal C. Paniello, Jose Zevallos, Wade Thorstad, Douglas R. Adkins

ORCID

nab-Paclitaxel-based induction chemotherapy followed by cisplatin and radiation therapy for human papillomavirus-unrelated head and neck squamous-cell carcinoma

Upload

Missing publications? Search for publications with a matching author name.